SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001363585-13-000006
Filing Date
2013-04-01
Accepted
2013-04-01 16:29:10
Documents
1
Period of Report
2013-04-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 4216
  Complete submission text file 0001363585-13-000006.txt   5580
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANADA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Issuer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
SIC: 2834 Pharmaceutical Preparations

Mailing Address 33 HARBOUR SQUARE TORONTO A6 M5J 2G2
Business Address
Brusegard David (Reporting) CIK: 0001516920 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-25169 | Film No.: 13731523